314 related articles for article (PubMed ID: 8895669)
1. Enhanced expression of tissue inhibitors of metalloproteinases in human colorectal tumors.
Murashige M; Miyahara M; Shiraishi N; Saito T; Kohno K; Kobayashi M
Jpn J Clin Oncol; 1996 Oct; 26(5):303-9. PubMed ID: 8895669
[TBL] [Abstract][Full Text] [Related]
2. Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer.
Gress TM; Müller-Pillasch F; Lerch MM; Friess H; Büchler M; Adler G
Int J Cancer; 1995 Aug; 62(4):407-13. PubMed ID: 7635566
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
[TBL] [Abstract][Full Text] [Related]
4. Role of tissue inhibitors of metalloproteinases (TIMPs) in colorectal carcinoma.
Joo YE; Seo KS; Kim J; Kim HS; Rew JS; Park CS; Kim SJ
J Korean Med Sci; 1999 Aug; 14(4):417-23. PubMed ID: 10485622
[TBL] [Abstract][Full Text] [Related]
5. In situ hybridization studies of metalloproteinases 2 and 9 and TIMP-1 and TIMP-2 expression in human prostate cancer.
Wood M; Fudge K; Mohler JL; Frost AR; Garcia F; Wang M; Stearns ME
Clin Exp Metastasis; 1997 May; 15(3):246-58. PubMed ID: 9174126
[TBL] [Abstract][Full Text] [Related]
6. Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastases.
Zeng ZS; Guillem JG
Br J Cancer; 1995 Sep; 72(3):575-82. PubMed ID: 7669564
[TBL] [Abstract][Full Text] [Related]
7. Expression of 72-kDa gelatinase (MMP-2), collagenase (MMP-1), and tissue metalloproteinase inhibitor (TIMP) in primary pig skin fibroblast cultures derived from radiation-induced skin fibrosis.
Lafuma C; El Nabout RA; Crechet F; Hovnanian A; Martin M
J Invest Dermatol; 1994 Jun; 102(6):945-50. PubMed ID: 8006459
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of MMP-2, MMP-9, and TIMP-2 in neuroblastoma: association with tumor progression and clinical outcome.
Ara T; Fukuzawa M; Kusafuka T; Komoto Y; Oue T; Inoue M; Okada A
J Pediatr Surg; 1998 Aug; 33(8):1272-8. PubMed ID: 9722003
[TBL] [Abstract][Full Text] [Related]
9. Role of the matrix metalloproteinase and tissue inhibitors of metalloproteinase families in noninvasive and invasive tumors transplanted in mice with severe combined immunodeficiency.
Furukawa A; Tsuji M; Nishitani M; Kanda K; Inoue Y; Kanayama H; Kagawa S
Urology; 1998 May; 51(5):849-53. PubMed ID: 9610608
[TBL] [Abstract][Full Text] [Related]
10. Expression of metalloproteinases and their inhibitors in adenocarcinoma of the uterine cervix.
Davidson B; Goldberg I; Liokumovich P; Kopolovic J; Gotlieb WH; Lerner-Geva L; Reder I; Ben-Baruch G; Reich R
Int J Gynecol Pathol; 1998 Oct; 17(4):295-301. PubMed ID: 9785129
[TBL] [Abstract][Full Text] [Related]
11. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors.
Terada T; Okada Y; Nakanuma Y
Hepatology; 1996 Jun; 23(6):1341-4. PubMed ID: 8675149
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of transforming growth factor-beta 1 on the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in young and old human fibroblasts.
Edwards DR; Leco KJ; Beaudry PP; Atadja PW; Veillette C; Riabowol KT
Exp Gerontol; 1996; 31(1-2):207-23. PubMed ID: 8706790
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans.
Kossakowska AE; Huchcroft SA; Urbanski SJ; Edwards DR
Br J Cancer; 1996 Jun; 73(11):1401-8. PubMed ID: 8645587
[TBL] [Abstract][Full Text] [Related]
14. The distribution of matrix metalloproteinases and tissue inhibitor of metalloproteinases in colorectal cancer.
Gallegos NC; Smales C; Savage FJ; Hembry RM; Boulos PB
Surg Oncol; 1995 Feb; 4(1):21-9. PubMed ID: 7780609
[TBL] [Abstract][Full Text] [Related]
15. Differential regulations of matrix metalloproteinases and tissue inhibitors of metalloproteinases in dermal fibroblasts by dibutyril cyclic AMP.
Kuroda K; Shinkai H
J Dermatol Sci; 1997 Aug; 15(2):95-100. PubMed ID: 9279690
[TBL] [Abstract][Full Text] [Related]
16. Matrilysin is associated with progression of colorectal tumor.
Ishikawa T; Ichikawa Y; Mitsuhashi M; Momiyama N; Chishima T; Tanaka K; Yamaoka H; Miyazakic K; Nagashima Y; Akitaya T; Shimada H
Cancer Lett; 1996 Oct; 107(1):5-10. PubMed ID: 8913260
[TBL] [Abstract][Full Text] [Related]
17. Higher concentrations of matrix metalloproteinases in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome.
Torii K; Iida K; Miyazaki Y; Saga S; Kondoh Y; Taniguchi H; Taki F; Takagi K; Matsuyama M; Suzuki R
Am J Respir Crit Care Med; 1997 Jan; 155(1):43-6. PubMed ID: 9001287
[TBL] [Abstract][Full Text] [Related]
18. [Gene expressions of type IV collagenase and tissue inhibitor of metalloproteinases (TIMP) in human bladder cancers].
Naruo S; Kanayama H; Aki M; Kagawa S
Nihon Hinyokika Gakkai Zasshi; 1993 May; 84(5):841-50. PubMed ID: 8320889
[TBL] [Abstract][Full Text] [Related]
19. High levels of tissue inhibitor of metalloproteinase-2 (TIMP-2) expression are associated with poor outcome in invasive bladder cancer.
Grignon DJ; Sakr W; Toth M; Ravery V; Angulo J; Shamsa F; Pontes JE; Crissman JC; Fridman R
Cancer Res; 1996 Apr; 56(7):1654-9. PubMed ID: 8603416
[TBL] [Abstract][Full Text] [Related]
20. In situ localization and quantification of seventy-two-kilodalton type IV collagenase in aneurysmal, occlusive, and normal aorta.
McMillan WD; Patterson BK; Keen RR; Pearce WH
J Vasc Surg; 1995 Sep; 22(3):295-305. PubMed ID: 7674473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
